{{Rsnum
|rsid=628031
|Gene=SLC22A1
|Chromosome=6
|position=160139813
|Orientation=plus
|GMAF=0.3021
|Gene_s=SLC22A1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 19.6 | 44.6 | 35.7
| HCB | 10.3 | 30.1 | 59.6
| JPT | 5.3 | 28.3 | 66.4
| YRI | 5.4 | 40.8 | 53.7
| ASW | 7.0 | 43.9 | 49.1
| CHB | 10.3 | 30.1 | 59.6
| CHD | 5.6 | 41.7 | 52.8
| GIH | 10.9 | 45.5 | 43.6
| LWK | 4.5 | 40.9 | 54.5
| MEX | 3.4 | 24.1 | 72.4
| MKK | 7.7 | 39.1 | 53.2
| TSI | 12.9 | 45.5 | 41.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=23223357
|Title=The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia
}}

{{PMID Auto
|PMID=22735389
|Title=Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients
}}

{{PMID Auto
|PMID=23996099
|Title=ABCB1 and ABCC1 variants associated with virological failure of first-line protease inhibitors antiretroviral regimens in Northeast Brazil patients
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}